We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.



Seahorse XF MitoTox Assay Kit for Mitochondrial Toxicity and Drug Safety Evaluation

Seahorse XF MitoTox Assay Kit for Mitochondrial Toxicity and Drug Safety Evaluation

The Agilent Seahorse XF Mito Tox Assay kit allows for the identification of drug-induced mitochondrial toxicity through direct functional measurements of mitochondrial oxygen consumption rates (OCR). It provides high sensitivity and specificity along with the toxicity mode of action in one assay, minimizing false positives and false negatives. The XF Mito Tox Assay Kit seamlessly integrates with Agilent Seahorse Pro Controller and Wave Pro software and Agilent Seahorse Analytics in the assay workflow, providing an end-to-end solution for assessing drug-induced mitochondrial toxicity

Product Specifications
Assay Wells 6x96 Well Assays
Assays Per Kit 6
For Use With Seahorse XF Pro Analyzer
Kit Contents 6 Full Plate Assays
Shipping Condition Ambient Temperature
Storage Temp Conditions Store at Room Temperature
About Agilent Technologies
Agilent Technologies is a global leader in life sciences, diagnostics and applied markets, recognized for uncompromising integrity in all they do. Their mission is to advance quality of life by focusing their expertise in six key markets. With a team of approximately 18,000 employees spread across the world, their global footprint includes sales offices, logistics centers and business facilities in three major geographies. Their worldwide capabilities enable them to deliver high-quality solutions to their valued customers in 110 countries.
Interested in seeing more content from Agilent Technologies?
Discover all their latest news, webinars, products and more by clicking the link below.